Miyawaki T, Kenmotsu H, Harada H, Ohde Y, et al. Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L). BMC Cancer 2021;21:1121.
PMID: 34663250